Psychotropic medication in chronic spinal disorders.
BACKGROUND
Optimal treatment of nonmalignant chronic spinal disorders (CSDs) may require the use of one or more nonopioid psychotropic medications. Vast research literature has documented high rates of psychiatric disorders in patients with CSDs. Psychotropic medications are one type of effective treatment for these disorders. Many medications of this type are also used as adjuvants to primary analgesic medications.


OBJECTIVE
Physicians treating CSDs may have little training and experience in prescribing psychotropic medications. Further, they may possess limited information about the efficacy of these types of medications in treating psychiatric disorders comorbid with CSDs or as adjunctive analgesics. Because of the wide variety (antidepressants, anxiolytics, sleep-promoting agents, anticonvulsants, neuroleptics, muscle relaxants) and numerous indications for psychiatric medications, a concise review of the use of psychotropic medications with CSD patients is offered for the spine specialist.


METHODS
A systematic review of the contemporary English literature on psychotropic medications in the CSD population.


METHODS
A computerized search of MEDLINE was performed on all English literature published from 1982 to August 2002.


RESULTS
Psychotropic medications have been found to be very efficacious in the large subgroup of patients with CSDs with psychiatric comorbidity, particularly patients with the common constellation of depression, anxiety, excessive somatic complaints, insomnia and irritability. Although the type of medication indicated depends on the particular psychiatric syndrome(s), antidepressants have been found to be extremely useful with the constellation described above. There is less evidence to support the use of nonopioid psychotropic medications in the treatment of nociceptive pain, although clinical experience indicates that some individuals demonstrate a marked analgesic response. Research support for the efficacy of particular psychotropic medications in treating neuropathic pain is stronger, although more controlled research is clearly needed.


CONCLUSIONS
Psychotropic medications are extremely useful in the treatment of psychiatric disorders comorbid with CSDs and modestly useful as analgesic adjuvants, particularly with pain of neuropathic etiology. Familiarity with these medications will aid the primary treating physician in optimizing outcomes in this difficult group of patients.
Polatin
Peter B
PB
Department of Anesthesia and Pain Management, University of Texas Southwestern Medical Center at Dallas, Eugene McDermott Center for Pain Management, 6263 Harry Hines Blvd., Dallas, TX 75235, USA. peter.polatin@utsouthwestern.edu
Dersh
Jeffrey
J
D002908:Chronic Disease; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D010147:Pain Measurement; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D018570:Risk Assessment; D012720:Severity of Illness Index; D013122:Spinal Diseases / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D016896:Treatment Outcome
D011619:Psychotropic Drugs